GE HealthCare (GEHC) announced the 510(k) submission to the FDA for CleaRecon DL, deep learning technology, designed to improve the quality of cone-beam computed tomography, or CBCT, images by bringing artificial intelligence, or AI-based 3D reconstruction to the interventional suite. This technology, which is pending 510(k) clearance, will be demonstrated at the Radiological Society of North America’s 2024 Annual Meeting taking place from December 1-4 in Chicago.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- GE HealthCare to acquire remaining 50% stake in Nihon Medi-Physics
- RadNet’s DeepHealth expands FDA clearance for SmartMammo solution
- RadNet price target raised to $94 from $80 at Truist
- RadNet’s DeepHealth expands FDA clearance for SmartMammo solutionGE
- GE Aerospace (NYSE:GE) Reaches $362.5M Settlement with Investors